Replies to post #8139 on Relief Therapeutics Holding AG (RLFTF)

[TarheelBuyer]

I would think that info would NOT be made public, businesses don't share the DD of their partnerships when it comes to finances, they only share the bottom line

[GMoney74]

i have asked this a dozen times and havent gotten a response. i also emaile d the company and asked to no avail. this is the only possible cloud on this trade so far imho.

[gastric]

Relief gets 100% according to chairman in this interview.

"Who owns the rights on Aviptadil?

Relief owns the patents on Aviptadil that are currently valid in the US and in Europe. In both jurisdictions we have orphan drug status, too."

"Who finances the ongoing trials?

Relief is paying for the trials. NeuroRx conducts the study on our behalf and we cover all the invoices."

"Do you have an agreement with NeuroRx about who receives how much of the profits from Aviptadil? Or is the drug fully owned by Relief?

Aviptadil is our drug.

You are entitled to all revenues it could create?

That is the current situation."



https://themarket.ch/interview/relief-therapeutics-our-drug-could-generate-hundreds-of-millions-of-dollars-per-year-ld.2478

Question since I have not seen it anywhere.

What is the split of revenue between Relief Therapeutics and NeuroRX for the sale of RLF-100?

Who gets what percentage of sales/revenues?